Skip to content

Radioprotective effect of melatonin in patient with rectal cancer

Radioprotective effect of melatonin on preventing of cancer-related thrombocytopenia in patient with rectal cancer

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016021626586N1
Enrollment
60
Registered
2016-03-03
Start date
2016-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: rectal cancer. Condition 2: radiation injury. Benign neoplasm: Rectum Exposure to ionizing radiation

Interventions

Intervention 1: Melatonin capsules containing 20 mg daily administered 1 hour before radiation therapy 5 days a week for 28 days. Intervention 2: Administration of a capsule containing 20 mg per day 5
Prevention
Placebo
Melatonin capsules containing 20 mg daily administered 1 hour before radiation therapy 5 days a week for 28 days
Administration of a capsule containing 20 mg per day 5 days per week wholemeal flour 1 hour before radiation therapy for 28 days.

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 60 patients with rectal cancer; aged 40 to 60 years with radiotherapy and chemotherapy same regime that still have not done surgery Exclusion criteria: patients with autoimmune diseases (purpura); von Willebrand's disease; patients that of aspirin drugs; sulfadiazine; daunorubicin use; individuals who previously had chemotherapy or radiotherapy; people who have a history of depression or suicidal feeling

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Thrombocytopenia. Timepoint: before beginning treatment and at the end of treatment. Method of measurement: CBC.

Secondary

MeasureTime frame
Thrombocytopenia. Timepoint: before beginning treatment and at the end of treatment. Method of measurement: CBC.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasim Kouhi Habibi Dehkordi

Babol University of Medical Sciences

n.kouhi@mubabol.ac.irkouhi.nasim@gmail.com+98 11 3219 9592

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 5, 2026